Related Practices
AVH offers a wide range of legal services to clients in the vital field of intellectual property law. AVH provides counseling and litigation services regarding patents, trade secrets, trademarks and copyrights.
AVH offers clients a full range of legal services in intellectual property law. While the firm focuses on patent litigation in a variety of industries, we also provide counseling and other litigation services regarding trade secrets, trademarks and copyrights. The firm represents clients seeking to enforce intellectual property rights and to avoid and defend against charges of infringement and misappropriation.
Many firms have an intellectual property practice, but AVH has earned a reputation over time as the go-to firm for high-profile matters of strategic importance. The firm has been asked to serve as lead trial counsel in the midst of or after the close of discovery of numerous occasions. Our attorneys are uniquely suited to assist clients in intellectual property matters. Not only do we possess extensive patent and technical experience, but we are also seasoned litigators and trial attorneys.
Our attorneys endeavor to link business, law and science. This ability means that we understand the particular business goals of our clients, the nuances of the law and the strategies needed to exploit the technical subject matter at issue.
News
- AVH Partners Named Connecticut Rising Stars 2011/2012
- AVH Partners Named Connecticut Super Lawyers 2011/2012
- AVH Partners Named to Super Lawyers Business Edition 2011
- AVH Partner Chad Landmon Honored as Hartford Business Journal “40 Under 40” Winner
- AVH Partner Jonathan Harris Speaks with the Hartford Business Journal about Small Green Firm Winning Patent
- AVH Assisted Actavis in Resolving Ten-Year-Old Dispute with Pfizer
- AVH Partner, Associate Pen Article on Biosimilar Approval Standards Under BPCI
- View More ›
Articles & Newsletters
- Formulation Patents and Dermatology and Obviousness
- Innovative Procedures v. Premarketing Approval
- Final Word: Advocating for Biosimilar Approval Standards under BPCI
- Machine-Or-Transformation Test After Myriad: Implications To The Prosecution Of Process Claims, Practising Law Institute, Patent Law Practice Center, August 15, 2011
- Heightened Standard For The Entire Market Value Rule?
- Do You Have The Right To Sue: Understanding Contract Provisions in The Context of Litigation
- Viewpoint: Advocating for Biosimilar Approval Standards under BPCI
- View More ›
Attorney Contacts
- Lauren S. Albert
- Matthew J. Becker
- Michael A. Davitz, M.D.
- Nicholas E.O. Gaglio
- Jonathan A. Harris
- Chad A. Landmon
- Jeremy C. Lowe
- Francis H. Morrison III
- James D. Veltrop
Speaking Engagements & Seminars
- CBI's 4th Annual Bio/Pharmaceutical Drug Safety Forum
- University of Connecticut, School of Law, Adjunct Professor in Patent Litigation, Spring 2012
- Michael Bednarek Discusses Factors Reshaping In-house Patent Strategies
- ACI's FDA Boot Camp Post-Conference Workshop: Non-Patent Marketing Exclusivities: Challenges, Opportunities and Current Controversies
- ACI's FDA Boot Camp: Bioequivalence - What Patent Lawyers Need to Know
- "Patent Due Diligence - A Good Business Practice"
- "How the Dynamics of Biosimilars Are Changing the Hatch-Waxman Landscape"
- Jonathan Harris Leads Seminar Entitled, "Prior Art and Obviousness 2011: Current Trends in Sections 102 & 103"
- AIPLA Mid-Winter Institute, meeting of the Special Committee on the FDA: Discussion of the FDA Hearings on the Biologics Price Compeitition and Innovation Act
- "Paragraph IV Disputes and Litigation." ACI Hatch-Waxman Boot Camp (2011)
- "Biosimilars and Biointerchangeables," Hatch-Waxman Boot Camp, American Conference Institute
- "Inventorship & Priority of Invention," Prior Art and Obviousness: Current Trends in Sections 102 and 103, Practicing Law Institute
- "Pre-Trial Tactics for Brands and Generics." ACI Paragraph IV Disputes Conference (2010)
- ACI's Paragraph IV on Trial: Litigator's Master Class on Paragraph IV Pre-Trial Preparation
- CBI's Pharmaceutical Congress on Paragraph IV Disputes and Settlements: Workshop Leader on Assessing Paragraph IV Litigation Strategies
- "Medical Process Claims after Bilski and Promethius," Maximizing Pharmaceutical Patent Life Cycles, American Conference Institute
- "Patent Litigation Strategies for Follow-on Biologics," Generic Pharmaceutical Association GphA Annual Meeting
- "Bioequivalence in Paragraph IV Patent Infringement Litigation," FDA Boot Camp, American Conference Institute
- Assessing the Patent and FDA Strategies for Follow-On Biologics to Maximize Sucess
- FDAnews Webinar: Assessing the Patent and FDA Strategies for Follow-On Biologics to Maximize Success
- ACI's Paragraph IV Disputes: Advanced Master Class - Obtaining Optimal Terms and Mitigating Antitrust Concerns When Settling Paragraph IV Disputes
- CBI's Annual Summit on Biosimilars and Follow-On Biologics
- "Developing Profits from Patent Assets." NIBA (2009)
- "Intellectual Property and Ethics - Annual Review." AIPLA Annual Meeting (2009)
- "Practical Guidelines for Assessing the Doctrine of Equivalence and Invalidity in Patent Opinion Writing," Pharmaceutical and Biotech Patent Opinion Writing, American Conference Institute
- ACI's Paragraph IV on Trial: Litigator's Master Class on Paragraph IV Pre-Trial Preparation
- CBI's Pharmaceutical Congress on Paragraph IV Disputes
- "The Patent Playbook." LES International Annual Meeting (2008)
- FDAnews Audioconference: Navigating the FDA's New 180-Day Generic Marketing Exclusivity Rulings
- Guest Lecturer at the University of Connecticut School of Law
- Collaborating Attorney to the Connecticut Intellectual Property Notes
- "Avoiding Compulsory Licenses in the Post-eBay Era." LES Spring Meeting (2007)